Biomarker-based strategy for early discontinuation of empirical antifungal treatment in critically ill patients: a randomized controlled trial

Intensive care medicine research agenda on invasive fungal infection in critically ill patients

(2017) Matteo Bassetti et al.   INTENSIVE CARE MEDICINE

Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016

(2017) Andrew Rhodes et al.   INTENSIVE CARE MEDICINE

Empirical Micafungin Treatment and Survival Without Invasive Fungal Infection in Adults With ICU-Acquired Sepsis, Candida Colonization, and Multiple Organ Failure

(2016) Jean-Francois Timsit et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

(1,3)-β-d-Glucan-based antifungal treatment in critically ill adults at high risk of candidaemia: an observational study

(2016) Brunella Posteraro et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Impact of antifungal prescription on relative distribution and susceptibility of Candida spp. – Trends over 10 years

(2016) Sébastien Bailly et al.   JOURNAL OF INFECTION

(1, 3)-β-D-glucan assay for diagnosing invasive fungal infections in critically ill patients with hematological malignancies

(2016) Elie Azoulay et al.   Oncotarget

Systemic antifungal therapy for proven or suspected invasive candidiasis: the AmarCAND 2 study

(2016) Olivier Leroy et al.   Annals of Intensive Care

Failure of Empirical Systemic Antifungal Therapy in Mechanically Ventilated Critically Ill Patients

(2015) Sébastien Bailly et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America

(2015) Peter G. Pappas et al.   CLINICAL INFECTIOUS DISEASES

Antifungal de-escalation was not associated with adverse outcome in critically ill patients treated for invasive candidiasis: post hoc analyses of the AmarCAND2 study data

(2015) Sébastien Bailly et al.   INTENSIVE CARE MEDICINE

Combination ofCandidabiomarkers in patients receiving empirical antifungal therapy in a Spanish tertiary hospital: a potential role in reducing the duration of treatment

(2015) M. Carmen Martínez-Jiménez et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Breakpoints for antifungal agents: An update from EUCAST focussing on echinocandins against Candida spp. and triazoles against Aspergillus spp.

(2014) Maiken C. Arendrup et al.   DRUG RESISTANCE UPDATES

What’s new in the clinical and diagnostic management of invasive candidiasis in critically ill patients

(2014) Cristóbal León et al.   INTENSIVE CARE MEDICINE

Resistance of Candida spp. to antifungal drugs in the ICU: where are we now?

(2014) Danièle Maubon et al.   INTENSIVE CARE MEDICINE

Prognostic factors and historical trends in the epidemiology of candidemia in critically ill patients: an analysis of five multicenter studies sequentially conducted over a 9-year period

(2014) Arnaldo L. Colombo et al.   INTENSIVE CARE MEDICINE

Worrisome trends in incidence and mortality of candidemia in intensive care units (Paris area, 2002–2010)

(2014) Olivier Lortholary et al.   INTENSIVE CARE MEDICINE

Factors predicting prolonged empirical antifungal treatment in critically ill patients

(2014) Mohamed Zein et al.   Annals of Clinical Microbiology and Antimicrobials

Increasing Echinocandin Resistance in Candida glabrata: Clinical Failure Correlates With Presence of FKS Mutations and Elevated Minimum Inhibitory Concentrations

(2013) Barbara D. Alexander et al.   CLINICAL INFECTIOUS DISEASES

Comparison of (1->3)- -D-Glucan, Mannan/Anti-Mannan Antibodies, and Cand-Tec Candida Antigen as Serum Biomarkers for Candidemia

(2013) J. Held et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Septic Shock Attributed to Candida Infection: Importance of Empiric Therapy and Source Control

(2012) M. Kollef et al.   CLINICAL INFECTIOUS DISEASES

ESCMID* *This guideline was presented in part at ECCMID 2011. European Society for Clinical Microbiology and Infectious Diseases. guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients

(2012) O.A. Cornely et al.   CLINICAL MICROBIOLOGY AND INFECTION

Systemic antifungal therapy in critically ill patients without invasive fungal infection*

(2012) Elie Azoulay et al.   CRITICAL CARE MEDICINE

β-D-glucan Surveillance with Preemptive Anidulafungin for Invasive Candidiasis in Intensive Care Unit Patients: A Randomized Pilot Study

(2012) Kimberly E. Hanson et al.   PLoS One

Invasive Mycoses: Diagnostic Challenges

(2011) Luis Ostrosky-Zeichner   AMERICAN JOURNAL OF MEDICINE

 -D-Glucan Assay for the Diagnosis of Invasive Fungal Infections: A Meta-analysis

(2011) D. E. Karageorgopoulos et al.   CLINICAL INFECTIOUS DISEASES

Recent Exposure to Caspofungin or Fluconazole Influences the Epidemiology of Candidemia: a Prospective Multicenter Study Involving 2,441 Patients

(2010) Olivier Lortholary et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Candida bloodstream infections in intensive care units: Analysis of the extended prevalence of infection in intensive care unit study*

(2010) Daniel H. Kett et al.   CRITICAL CARE MEDICINE

Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: A multicenter, prospective, observational study in France (2005–2006)

(2009) Olivier Leroy et al.   CRITICAL CARE MEDICINE

Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group

(2008) Ben De Pauw et al.   CLINICAL INFECTIOUS DISEASES